A detailed history of Bdo Wealth Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bdo Wealth Advisors, LLC holds 2,816 shares of REGN stock, worth $2.08 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
2,816
Previous 2,788 1.0%
Holding current value
$2.08 Million
Previous $2.29 Million 11.66%
% of portfolio
0.23%
Previous 0.28%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 01, 2023

BUY
$700.03 - $830.35 $19,600 - $23,249
28 Added 1.0%
2,816 $2.02 Million
Q1 2023

May 09, 2023

SELL
$680.49 - $826.97 $50,356 - $61,195
-74 Reduced 2.59%
2,788 $2.29 Million
Q4 2022

Jan 27, 2023

SELL
$705.89 - $766.39 $29,647 - $32,188
-42 Reduced 1.45%
2,862 $0
Q3 2022

Nov 02, 2022

SELL
$573.97 - $724.32 $84,373 - $106,475
-147 Reduced 4.82%
2,904 $2 Million
Q2 2022

Aug 25, 2022

SELL
$548.35 - $738.84 $2,193 - $2,955
-4 Reduced 0.13%
3,051 $1.8 Million
Q1 2022

May 06, 2022

BUY
$595.12 - $698.43 $51,775 - $60,763
87 Added 2.93%
3,055 $2.13 Million
Q4 2021

Feb 11, 2022

BUY
$543.48 - $670.97 $74,456 - $91,922
137 Added 4.84%
2,968 $1.87 Million
Q3 2021

Nov 09, 2021

BUY
$574.03 - $680.96 $45,922 - $54,476
80 Added 2.91%
2,831 $1.71 Million
Q2 2021

Sep 03, 2021

BUY
$472.8 - $558.54 $1.21 Million - $1.43 Million
2,554 Added 1296.45%
2,751 $1.54 Million
Q1 2021

May 14, 2021

BUY
$446.73 - $548.2 $84,878 - $104,158
190 Added 2714.29%
197 $93,000
Q3 2020

Nov 12, 2020

BUY
$544.75 - $658.21 $3,813 - $4,607
7 New
7 $4,000
Q1 2019

May 15, 2019

SELL
$372.08 - $439.57 $18,604 - $21,978
-50 Closed
0 $0
Q2 2018

Aug 27, 2018

BUY
$284.6 - $344.99 $14,230 - $17,249
50 New
50 $17,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Bdo Wealth Advisors, LLC Portfolio

Follow Bdo Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bdo Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bdo Wealth Advisors, LLC with notifications on news.